Feline HER2 antibody and antigen (recombinant protein)
Diagnostic anti-Feline HER2 antibodies pairs and antigen for animal health (animal Cat/Feline breast cancer) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT
Go to Companion Animal disease testing products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-FEL-HER2-Ag01 | Feline HER2 | $3090.00 |
GMP-FEL-HER2-Ab01 | Anti-Feline HER2 mouse monoclonal antibody (mAb) | $3090.00 |
GMP-FEL-HER2-Ab02 | Anti-Feline HER2 mouse monoclonal antibody (mAb) | $3090.00 |
GMP-FEL-HER2-Ab03 | Anti-Feline HER2 human monoclonal antibody (mAb) | $3090.00 |
GMP-FEL-HER2-Ab04 | Anti-Feline HER2 human monoclonal antibody (mAb) | $3090.00 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. | GMP-FEL-HER2-Ag01 |
Product Name | Feline HER2 |
Target/Biomarker | Feline HER2 |
Expression platform | E.coli |
Isotypes | Recombinant Antigen |
Bioactivity validation | Anti-Feline HER2 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in HER2 level test of animal Cat/Feline with breast cancer. |
Tag | His | Reconized/Reactive Specics | Feline HER2 |
Product description | Recombinant Feline HER2 protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. | GMP-FEL-HER2-Ab01,GMP-FEL-HER2-Ab02 |
Target/Biomarker | Feline HER2 |
Product Name | Anti-Feline HER2 mouse monoclonal antibody (mAb) |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Recombinant Feline HER2 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Feline HER2 antibodies in Feline HER2 level test of animal Cat/Feline with breast cancer. |
Product description | Anti-Feline HER2 mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Feline HER2 antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. | GMP-FEL-HER2-Ab03,GMP-FEL-HER2-Ab04 |
Target/Biomarker | Feline HER2 |
Product Name | Anti-Feline HER2 human monoclonal antibody (mAb) |
Expression platform | CHO |
Isotypes | Human lgG1 |
Bioactivity validation | Recombinant Feline HER2 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Feline HER2 antibodies in Feline HER2 level test of animal Cat/Feline with breast cancer. |
Product description | Anti-Feline HER2 mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker Information
The measurement of HER2 in cats has profound scientific and clinical significance. Firstly, it serves as a valuable diagnostic tool for identifying specific types of cancer, especially within the context of feline mammary gland tumors. HER2 overexpression is a common feature of some feline mammary tumors, and measuring HER2 levels can help veterinarians differentiate between tumor subtypes and assess tumor aggressiveness. This information is critical for developing treatment strategies tailored to the unique characteristics of each patient's cancer.
Secondly, HER2-targeted therapies have emerged as a promising approach in the treatment of HER2-positive cancers in cats. These therapies aim to block the abnormal signaling of HER2, inhibiting uncontrolled cell growth. Accurate measurement of HER2 expression is essential for identifying cats that may benefit from these targeted treatments. Additionally, monitoring HER2 levels during treatment can provide insights into treatment response and guide adjustments to the therapeutic approach.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.